Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases

Autoři: Leolin Katsidzira aff001;  Anna Vorster aff002;  Innocent T. Gangaidzo aff001;  Rudo Makunike-Mutasa aff004;  Dhiren Govender aff005;  Simbarashe Rusakaniko aff006;  Sandie Thomson aff007;  Jonathan A. Matenga aff001;  Raj Ramesar aff002
Působiště autorů: Department of Medicine, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe aff001;  MRC/UCT Research Unit for Genomic and Precision Medicine, Division of Human Genetics, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa aff002;  Central Analytical Facility (CAF), DNA Sequencing Unit, Stellenbosch University, Stellenbosch, South Africa aff003;  Department of Histopathology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe aff004;  Division of Anatomical Pathology, Faculty of Health Sciences, University of Cape Town, and National Health Laboratory Service Groote Schuur hospital, Cape Town, South Africa aff005;  Department of Community Medicine, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe aff006;  Division of Gastroenterology, Department of Medicine, University of Cape Town, Cape Town, Groote Schuur Hospital, Cape Town, South Africa aff007
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article



Approximately 25% of colorectal cancer patients in sub-Saharan Africa are younger than 40 years, and hereditary factors may contribute. We investigated the frequency and patterns of inherited colorectal cancer among black Zimbabweans.


A population-based cross-sectional study of ninety individuals with a new diagnosis of colorectal cancer was carried out in Harare, Zimbabwe between November 2012 and December 2015. Phenotypic data was obtained using interviewer administered questionnaires, and reviewing clinical and pathology data. Cases were screened for mismatch repair deficiency by immunohistochemistry and/or microsatellite instability testing, and for MLH1, MSH2 and EPCAM deletions using multiplex ligation-dependent probe amplification. Next generation sequencing using a 16-gene panel was performed for cases with phenotypic features consistent with familial colorectal cancer. Variants were assessed for pathogenicity using the mean allele frequency, phenotypic features and searching online databases.


Three Lynch syndrome cases were identified: MSH2 c.2634G>A pathogenic mutation, c.(1896+1_1897–1)_(*193_?)del , and one fulfilling the Amsterdam criteria, with MLH1 and PMS2 deficiency, but no identifiable pathogenic mutation. Two other cases had a strong family history of cancers, but the exact syndrome was not identified. The prevalence of Lynch syndrome was 3·3% (95% CI 0·7–9·4), and that of familial colorectal cancer was 5·6% (95% CI, 1·8–12·5).


Identifying cases of inherited colorectal cancer in sub-Saharan Africa is feasible, and our findings can inform screening guidelines appropriate to this setting.

Klíčová slova:

Africa – Colon – Colorectal cancer – Next-generation sequencing – Rectum – Zimbabwe – Hereditary nonpolyposis colorectal cancer – Mismatch repair


1. Katsidzira L, Gangaidzo I, Thomson S, Rusakaniko S, Matenga J, Ramesar R. The shifting epidemiology of colorectal cancer in sub-Saharan Africa. Lancet Gastroenterol Hepatol. 2017;2(5):377–83. doi:10.1016/S2468-1253(16)30183-2 28397702.

2. Chokunonga E, Borok M, Chirenje Z, Nyakabau A, Parkin D. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010. Int J Cancer. 2013;133(3):721–9. Epub 4 Mar 2013. doi:10.1002/ijc.28063 23364833

3. Katsidzira L, Gangaidzo IT, Makunike-Mutasa R, Manyanga T, Matsena-Zingoni Z, Thomson S, et al. A case-control study of risk factors for colorectal cancer in an African population. Eur J Cancer Prev. 2018. doi:10.1097/CEJ.0000000000000439 29649072.

4. Katsidzira L, Laubscher R, Gangaidzo IT, Swart R, Makunike-Mutasa R, Manyanga T, et al. Dietary patterns and colorectal cancer risk in Zimbabwe: A population based case-control study. Cancer epidemiology. 2018;57:33–8. doi:10.1016/j.canep.2018.09.005 30286315.

5. Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, et al. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. JAMA Oncol. 2017;3(4):464–71. doi:10.1001/jamaoncol.2016.5194 27978560; PubMed Central PMCID: PMC5564179.

6. Limburg PJ, Harmsen WS, Chen HH, Gallinger S, Haile RW, Baron JA, et al. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol. 2011;9(6):497–502. doi:10.1016/j.cgh.2010.10.021 21056691; PubMed Central PMCID: PMC3058119.

7. Cronje L, Paterson A, Becker P. Colorectal cancer in South Africa: A heritable cause suspected in many young black patients. S Afr Med J. 2009;99(2):103–6. 19418671

8. Katsidzira L, Chokunonga E, Gangaidzo IT, Rusakaniko S, Borok M, Matsena-Zingoni Z, et al. The incidence and histo-pathological characteristics of colorectal cancer in a population based cancer registry in Zimbabwe. Cancer epidemiology. 2016;44:96–100. doi:10.1016/j.canep.2016.08.001 27541963.

9. Raskin L, Dakubo JC, Palaski N, Greenson JK, Gruber SB. Distinct molecular features of colorectal cancer in Ghana. Cancer epidemiology. 2013;37(5):556–61. Epub 2013/08/22. doi:10.1016/j.canep.2013.07.007 23962701; PubMed Central PMCID: PMC4267222.

10. Williams R, White P, Nieto J, Vieira D, Francois F, Hamilton F. Colorectal Cancer in African Americans: An Update. Clin Transl Gastroenterol. 2016;7(7):e185. doi:10.1038/ctg.2016.36 27467183; PubMed Central PMCID: PMC4977418.

11. Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013;62(6):812–23. doi:10.1136/gutjnl-2012-304356 23408351; PubMed Central PMCID: PMC3647358.

12. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96(4):261–8. Epub 2004/02/19. doi: 10.1093/jnci/djh034 14970275; PubMed Central PMCID: PMC2933058.

13. Pérez-Cabornero L, Borrás Flores E, Sanz MI, Sampedro EV, Becares AA, Aras EL, et al. Characterization of New Founder Alu-Mediated Rearrangements in <em>MSH2</em> Gene Associated with a Lynch Syndrome Phenotype. Cancer Prevention Research. 2011;4(10):1546. doi:10.1158/1940-6207.CAPR-11-0227 21778331

14. Pérez-Cabornero L, Infante M, Velasco E, Lastra E, Miner C, Durán M. Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays. The Journal of Molecular Diagnostics. 2013;15(3):380–90. doi: doi: 10.1016/j.jmoldx.2013.02.003 23523604

15. Yurgelun MB, Allen B, Kaldate RR, Bowles KR, Judkins T, Kaushik P, et al. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. Gastroenterology. 2015;149(3):604-13.e20. doi:10.1053/j.gastro.2015.05.006 25980754

16. Ballester V, Rashtak S, Boardman L. Clinical and molecular features of young-onset colorectal cancer. World journal of gastroenterology: WJG. 2016;22(5):1736–44. doi:10.3748/wjg.v22.i5.1736 26855533; PubMed Central PMCID: PMC4724605.

17. Jasperson K, Tuohy T, Neklason D, Burt R. Hereditary and familial colon cancer. Gastroenterology. 2010;138:2044–58. doi: 10.1053/j.gastro.2010.01.054 20420945

18. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26(35):5783–8. doi:10.1200/JCO.2008.17.5950 18809606; PubMed Central PMCID: PMC2645108.

19. Stoffel EM, Koeppe E, Everett J, Ulintz P, Kiel M, Osborne J, et al. Germline Genetic Features of Young Individuals with Colorectal Cancer. Gastroenterology. 2017. doi:10.1053/j.gastro.2017.11.004 29146522.

20. Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2014;147(2):502–26. doi:10.1053/j.gastro.2014.04.001 25043945.

21. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H. Part I: Cancer in Indigenous Africans—burden, distribution, and trends. Lancet Oncol. 2008;9(7):683–92. doi:10.1016/S1470-2045(08)70175-X 18598933.

22. Laiyemo AO, Brawley O, Irabor D, Boutall A, Ramesar RS, Madiba TE. Toward colorectal cancer control in Africa. Int J Cancer. 2016;138(4):1033–4. doi:10.1002/ijc.29843 26355906; PubMed Central PMCID: PMC4715543.

23. Lindor N, Bugart L, Leontovich O, Goldberg R, Cunningham J, Sargent D, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumours. Journal of Clinical Oncology. 2002;20(4):1043–8. doi: 10.1200/JCO.2002.20.4.1043 11844828

24. Wang W, Dong L, Zou S, Lu N. Use of MLH1 methylation analysis versus BRAF V600E mutation testing to select patients for Lynch syndrome genetic testing in a Chinese population: A large consecutive cohort study. Journal of Clinical Oncology. 2019;37(4_suppl):493-. doi:10.1200/JCO.2019.37.4_suppl.493

25. Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, et al. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017;35(10):1086–95. doi:10.1200/JCO.2016.71.0012 28135145; PubMed Central PMCID: PMC5455355.

Článek vyšel v časopise


2019 Číslo 10
Nejčtenější tento týden